Skip to main content
. 2018 Dec 18;2018:6594169. doi: 10.1155/2018/6594169

Table 2.

Association between haplotypes of PSORS1C1 and STARD3 and NM23 expression.

Haplotypes NM23 Ad OR P–value Ad HROS P–value Ad HRRFS P–value
1+ 2+ 3+  (95% CI)  (95% CI) (95% CI)
PSORS1C1
 TGCACA 40 273 61 63 Ref. Ref. Ref.
 CAGGTG 37 171 19 20 0.44
(0.3 0–0.65)
2.70 × 10 -5 0.71
(0.42–1.22)
0.219 0.87
(0.46–1.63)
0.653
 CAGACA 6 64 9 5 0.56
(0.32–0.99)
0.048 0.99
(0.65–1.51)
0.967 1.66
(0.95–2.90)
0.073
 Othersa 3 36 3 6 0.60
(0.3 0–1.18)
0.135 0.97
(0.74–1.27)
0.805 2.04
(0.99–4.20)
0.054
 All othersb 46 271 31 31 0.48
(0.35–0.68)
2.05 × 10 -5 0.93
(0.73–1.18)
0.561 0.74
(0.50–1.10)
0.136
STARD3
 GG 46 329 58 69 Ref. Ref.
 Othersc 40 209 34 25 0.65
(0.47–0.91)
0.012 0.97
(0.76–1.24)
0.814 1.18
(0.74–1.88)
0.498

Note. OR, HR and P–value are adjusted for age, gender, race, smoking status, drinking status, BMI, BCLC stage, Child–Pugh stage, preoperative serum AFP level, TACE status before hepatectomy, pathological grade, cirrhosis, intrahepatic metastasis, PVTT, regional invasion, radical resection, and use of antiviral therapies. aOthers include CGCACA and CGGGCA. bThe group of all others is merged CAGGTG, CAGACA, CGCACA, and CGGGCA. cOthers include CA, GA, CG, and the total number of patients harbour GA and CG is 6.

Abbreviations. OR: odds ratio; HR: hazard ratio; 95% CI: 95% confidence intervals; Ad: adjusted.